Individual development and uPA–receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Nature Medicine

• Publication date

  1995-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/NM1095-1035PMID 7489359
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells

  2004cited by this paper
• The Catalog of Human Cytokeratins: Patterns of Expression in Normal Epithelia, Tumors and Cultured Cells Review

  2004cited by this paper
• Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system.

  1995cited by this paper
• Detection and management of bone marrow micrometastases in breast cancer.

  1994cited by this paper
• Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.

  1994cited by this paper
• Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction.

  1994cited by this paper
• Detection and management of bone marrow micrometastases in breast cancer.

  1994cited by this paper
• Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?

  1994cited by this paper
• Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness

  1993cited by this paper
• Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells.

  1993cited by this paper
• Solid tumour with initial presentation in the bone marrow—a clinicopathologic study of 25 adult cases

  1993cited by this paper
• Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients.

  1992cited by this paper
• Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers.

  1992cited by this paper
• The role of proteolytic enzymes in cancer invasion and metastasis

  1992cited by this paper
• Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients.

  1991cited by this paper
• Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.

  1991cited by this paper
• In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion

  1991cited by this paper
• Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.

  1991cited by this paper
• Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer.

  1990cited by this paper
• The distribution of secondary growths in cancer of the breast. 1889.

  1989cited by this paper
• The fate of bone marrow micrometastases in patients with primary breast cancer.

  1989cited by this paper
• The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis.

  1988cited by this paper
• Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.

  1987cited by this paper
• Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

  1986cited by this paper
• Detection of metastatic tumour cells in routine bone marrow smears by immuno‐alkaline phosphatase labelling with monoclonal antibodies

  1985cited by this paper
• Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

  1984cited by this paper
• The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells.

  1982cited by this paper
• Metastasis results from preexisting variant cells within a malignant tumor.

  1977cited by this paper
• Letter: Lower oesophageal sphincter.

  1974cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025

  2025influential citation
• Development of Cyclic Peptide‐Based Radiotracers for uPAR

  2025cites this paper
• A Cyclic Peptide-Based Radiotheranostic Agent for Urokinase-Type Plasminogen Activator in Tumors.

  2025cites this paper
• Liquid biopsy: An arsenal for tumour screening and early diagnosis.

  2024cites this paper
• Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers

  2024cites this paper
• Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma.

  2024cites this paper
• Circulating tumour cells for early detection of clinically relevant cancer

  2023cites this paper
• JAK1 Is a Novel Target of Tumor- and Invasion-Suppressive microRNA 494-5p in Colorectal Cancer

  2023cites this paper
• Therapeutic strategies targeting uPAR potentiate anti–PD-1 efficacy in diffuse-type gastric cancer

  2022cites this paper
• Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells

  2021cites this paper
• Minimal residual disease in advanced or metastatic solid cancers: the G0-G1 state and immunotherapy are key to unwinding cancer complexity.

  2020cites this paper
• The force awakens: metastatic dormant cancer cells

  2020cites this paper
• Defining the "Metastasome": Perspectives from the genome and molecular landscape in colorectal cancer for metastasis evolution and clinical consequences.

  2020cites this paper
• Helicobacter pylori Colonization Drives Urokinase Receptor (uPAR) Expression in Murine Gastric Epithelium During Early Pathogenesis

  2020cites this paper
• EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells

  2019cites this paper
• Notch and breast cancer metastasis: Current knowledge, new sights and targeted therapy

  2019influential citation
• Notch and Breast Cancer Metastasis

  2018cites this paper
• Relevance of the plasminogen activation system in the pathogenesis and progression of gastric cancer

  2018influential citation
• Epithelial-to-mesenchymal transition in cancer: complexity and opportunities

  2018cites this paper
• Hypoxia and Bone Metastatic Disease

  2017cites this paper
• Micrometastatic Dormancy in Uveal Melanoma: A Comprehensive Review of the Evidence, Mechanisms, and Implications for Future Adjuvant Therapies.

  2017cites this paper
• The Bone Marrow Microenvironment as a Regulator of Tumor Dormancy

  2016cites this paper
• Assessment of Health Hazards of Passive Tobacco Smoking in School-age Children; Role of Oxidative Stress Biomarkers and Nitric Oxide Metabolites

  2016cites this paper
• Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells

  2016cites this paper
• Clinicopathological and prognostic significance of circulating tumor cells in patients with gastric cancer: A meta‐analysis

  2015influential citation
• uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery

  2015cites this paper
• Soluble urokinase-type plasminogen activator receptor and ferritin concentration in patients with advanced alimentary tract carcinoma. Relationship to localization, surgical treatment and the stage of the disease--preliminary report.

  2014cites this paper
• Determining the Role of Autophagy in HER2/neu-Induced Mammary Tumor Dormancy and Recurrence

  2013cites this paper
• The Many Spaces of uPAR: Delivery of Theranostic Agents and Nanobins to Multiple Tumor Compartments through a Single Target

  2013cites this paper
• ADAM and EMMPRIN: a promising couple for more prognostic precision in patients with gastric cancer

  2013cites this paper
• From cell surface to nucleus:Unraveling cancer metastasis and the role of nucleophosmin in breast cancer

  2013cites this paper
• Tumor metastasis: moving new biological insights into the clinic

  2013cites this paper
• Prof. Dr. Dr. h. c. Karl-Walter Jauch – Präsident der Deutschen Gesellschaft für Chirurgie 2012/2013

  2013cites this paper
• Molecular Pathology of Cancer Metastasis: Suggestions for Future Therapy

  2012cites this paper
• Disseminated and circulating tumour cells and their role in breast cancer.

  2012cites this paper
• Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study

  2012cites this paper
• Plasma hepatocyte growth factor elevation may be associated with early metastatic disease in primary lung cancer patients.

  2012cites this paper
• Humoral innate immune response and disease

  2012cites this paper
• A Flexible Multidomain Structure Drives the Function of the Urokinase-type Plasminogen Activator Receptor (uPAR)*

  2012cites this paper
• Prognosis in adenocarcinomas of lower oesophagus, gastro‐oesophageal junction and cardia evaluated by uPAR‐immunohistochemistry

  2012cites this paper
• Urokinase plasminogen activator receptor on invasive cancer cells: A prognostic factor in distal gastric adenocarcinoma

  2012cites this paper
• Clinical Significance of Molecular Detection of Matrix metalloproteinase-1 in Bone Marrow and Peripheral Blood in Patients with Gastric Cancer

  2012cites this paper
• Microsoft Word-uPAR_SAXS_3.0-revision 1.1 J Biol Chem

  2012cites this paper
• Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells.

  2011cites this paper
• Prognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancer.

  2011cites this paper
• Do all roads lead to Rome? Routes to metastasis development

  2011cites this paper
• Micrometastasis: Detection methods and clinical importance

  2011cites this paper
• Minimal residual disease and circulating tumor cells in breast cancer

  2011cites this paper
• Clinical applications of the urokinase receptor (uPAR) for cancer patients.

  2011cites this paper
• Rational targeting of the urokinase receptor (uPAR): development of antagonists and non-invasive imaging probes.

  2011cites this paper
• Translational research on u-PAR.

  2010cites this paper
• Urokinase plasminogen activator receptor is expressed in invasive cells in gastric carcinomas from high‐ and low‐risk countries

  2010cites this paper
• Bestimmung des ER-alpha-Status von disseminierten Tumorzellen im Knochenmark bei Patientinnen mit primärem Mammakarzinom

  2010cites this paper
• Dormancy of Disseminated Tumor Cells: Reciprocal Crosstalk with the Microenvironment

  2010cites this paper
• Structure-based Engineering of Species Selectivity in the Interaction between Urokinase and Its Receptor

  2010cites this paper
• Lost in migration

  2010cites this paper
• Tumor lymphatics.

  2009cites this paper
• Prognostic impact of extracellular matrix metalloprotease inducer

  2009cites this paper
• The Prognostic Impact of Bone Marrow Micrometastases in Women with Breast Cancer

  2009cites this paper
• Das neuronale Zelladhäsionsmolekül L 1 als prognostischer Marker beim Kolonkarzinom

  2009cites this paper
• Urokinase receptor, MMP‐1 and MMP‐9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies

  2009cites this paper
• Preoperative u-PAR Gene Expression in Bone Marrow Indicates the Potential Power of Recurrence in Breast Cancer Cases

  2009cites this paper
• Cancer micrometastases

  2009cites this paper
• Urokinase‐plasminogen‐activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer

  2009cites this paper
• Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer

  2009cites this paper
• Cancer micrometastasis and tumour dormancy  

  2008cites this paper
• Proteome profiling of U2OS cell line in response to a prenylphenol antibiotic isolated from a phytopathogenic fungus.

  2008cites this paper
• Determination of uPA and PAI-1 by ELISA in Small Amounts of Breast Cancer Tissue: Clinical Evaluation in Pre- and Post-Primary Systemic Therapy Specimens.

  2008cites this paper
• Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases

  2008influential citation
• The urokinase receptor and its structural homologue C4.4A in human cancer: expression, prognosis and pharmacological inhibition.

  2008cites this paper
• Circulating Tumor Cells: Detection and Clinical Relevance

  2008cites this paper
• Pancreatic cancer: a generalized disease—prognostic impact of cancer cell dissemination

  2008cites this paper
• The urokinase receptor (u‐PAR)—a link between tumor cell dormancy and minimal residual disease in bone marrow?  

  2008cites this paper
• CirculatingTumor Cells and BoneMarrowMicrometastasis

  2008cites this paper
• Hematogenous Metastasis in Gastric Cancer Requires Isolated Tumor Cells and Expression of Vascular Endothelial Growth Factor Receptor-1

  2008cites this paper
• Circulating Tumor Cells and Bone Marrow Micrometastasis

  2008cites this paper
• Detection and characterization of disseminated tumor cells present in bone marrow of cancer patients

  2008cites this paper
• Urokinase receptor variants in tissue and body fluids.

  2007cites this paper
• Clinical significance of cytokeratin positive cells in bone marrow of gastric cancer patients

  2007cites this paper
• Detecting Carcinoma Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma by Immunomagnetic Beads and RT-PCR

  2007cites this paper
• Models, mechanisms and clinical evidence for cancer dormancy

  2007cites this paper
• A case of early gastric cancer with bone metastases: are bone marrow micrometastases significant?

  2007cites this paper
• Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer.

  2007cites this paper
• TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression.

  2007cites this paper
• L1 is associated with micrometastatic spread and poor outcome in colorectal cancer

  2007cites this paper
• Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors

  2007cites this paper
• Massive infiltration of bone marrow in colon carcinoma after treatment with activated protein C

  2007cites this paper
• Pdcd4, a colon cancer prognostic that is regulated by a microRNA.

  2007cites this paper
• Urokinase system expression in gastric carcinoma

  2006cites this paper
• Targeting urokinase-type plasminogen activator and its receptor for cancer therapy

  2006cites this paper
• Adverse effect of splenectomy on recurrence in total gastrectomy cancer patients with perioperative transfusion.

  2006cites this paper
• The Problem of Cancer Dormancy: Understanding the Basic Mechanisms and Identifying Therapeutic Opportunities

  2006cites this paper
• Is the Urokinase-type Plasminogen Activator System a Reliable Prognostic Factor in Gastric Cancer?

  2006cites this paper
• Regulation and Clinical Significance of Urokinase-Receptor (u-PAR), an Invasion-Related Molecule

  2006cites this paper
• Medical and Surgical Therapy for Gastric Cancer

  2006cites this paper
• Klinische Bedeutung des Nachweises minimaler Residualerkrankung bei Leukämien, Lymphomen und soliden Tumoren

  2006cites this paper
• Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients.

  2006cites this paper
• Molecular regulation of an invasion-related molecule--options for tumour staging and clinical strategies.

  2006cites this paper
• Die Transkription humaner Muzingene in Zellen unterschiedlicher Provenienz

  2006cites this paper
• Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer.

  2006cites this paper